Dear Investors and Supporters,

Quick note from Brooklyn—this week we’re kicking off patient patch testing as part of our ECG validation work. This marks an exciting milestone as we gather real-world comparative data to strengthen our FDA submission.

Also, a sincere thank you to everyone who’s visited our StartEngine campaign—and especially to those who followed up with an investment. Your continued support means everything.

🔗 https://www.startengine.com/offering/futurecardia

Onward,

Jae Bang